Surmodics, Inc. and its subsidiaries specialize in surface modification technologies for intravascular medical devices as well as chemical components for in vitro diagnostic immunoassay tests and microarrays both in the United States and internationally. The company operates in two primary segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment focuses on surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices. It also develops drug-delivery coating technologies that facilitate site-specific drug deliveries from the surface of devices targeting coronary, peripheral, neuro-vascular, structural heart markets, and beyond. Furthermore, this segment is involved in the design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons aimed at treating peripheral arterial disease and other applications. The IVD segment specializes in designing, developing, and manufacturing component products and technologies tailored for diagnostic immunoassays, molecular testing, and biomedical research applications, offering a range of products such as protein stabilization reagents, substrates, surface coatings, and antigens. The operating income ratio is -0.04 indicating the company's operational profitability margin. The company incurred an income tax expense of $4,036,000.00 indicating its tax obligations. The company's stock is identified with the symbol 'SRDX' in the market. Additionally, the operating expenses amount to $98,697,000.00 encompassing various operational costs incurred, and the company reported a net loss of -$11,542,000.00 indicating challenges in its operations. The stock is affordable at $31.02 making it suitable for budget-conscious investors. Furthermore, the stock has a low average trading volume of 77,213.00 indicating lower market activity, which may appeal to certain types of investors. With a market capitalization of $443,564,286.00 the company is classified as a small-cap player within the financial markets. Surmodics is a key player in the Medical - Devices industry, significantly contributing to the overall market landscape through its innovative offerings. Additionally, it belongs to the Healthcare sector, driving innovation and growth across its operational dimensions.